Penetration of target areas in the rat by liposome-associated agents administered parenterally and intragastrically.
D000284:Administration, Oral; D000818:Animals; D001761:Bleomycin / Q000008:administration & dosage / Q000378:metabolism*; D001786:Blood Glucose / Q000378:metabolism; D005949:Glucose Oxidase / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007328:Insulin / Q000494:pharmacology; D008081:Liposomes / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D009374:Neoplasms, Experimental / Q000378:metabolism*; D010716:Phosphatidylinositols / Q000494:pharmacology; D051381:Rats; D013154:Spleen / Q000378:metabolism
D001786:Blood Glucose; D007328:Insulin; D008081:Liposomes; D010716:Phosphatidylinositols; D001761:Bleomycin; D005949:Glucose Oxidase